Locations:
Search IconSearch

Opioid Consortium Takes a Regional Approach to Turn the Tide in Addiction Epidemic

What we've contributed, gained and learned through the partnership

In late May, U.S. Surgeon General Jerome Adams, MD, attended a meeting of the Northeast Ohio Hospital Opioid Consortium to learn what member partners are doing to combat the opioid crisis. With more than 47,000 Americans dying from overdoses involving opioids in 2017 — and 36% of those involving prescription opioids — Dr. Adams has made it a priority to curtail the epidemic. So too have partners of the consortium, including Cleveland Clinic.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Everyone in healthcare has a role to play in turning the tide of the opiate addiction epidemic,” says psychiatrist David Streem, MD, Section Head of the Alcohol and Drug Recovery Center in Cleveland Clinic’s Department of Psychiatry and Psychology. “Since there are people all over the world working to perpetuate our community’s abuse of opiates, we must work together with law enforcement, public leaders and organizational leadership to counter those efforts.”

Strength in numbers

A prime example of organizations working together, the Northeast Ohio Hospital Opioid Consortium is a hospital system-based, physician-led consortium that shares and implements best practices, promotes policy changes and increases prevention efforts. In addition to Cleveland Clinic, member partners include the MetroHealth System (the public health system for the county that includes Cleveland), the Northeast Ohio VA Healthcare System, St. Vincent’s Charity Medical Center and University Hospitals.

“We are fortunate to have so many top medical organizations in one area, each contributing to the opioid consortium by providing the pieces of the puzzle they are best suited to provide,” says Dr. Streem.

Contributing expertise through an endocarditis care bundle and more

One of Cleveland Clinic’s strengths is expertise in complicated narcotic withdrawal management cases.

For example, it has created an endocarditis care bundle that addresses the risk of chemical dependency for postsurgical patients who developed the infection through contaminated needles used while injecting illegal drugs. After surgery, patients often require weeks of IV antibiotic therapy, which can be problematic for IV drug users. Cleveland Clinic has developed a workflow to facilitate treatment, which includes chemical dependency counseling and discharge planning offered by Dr. Streem. Hospital leaders shared details of the endocarditis care bundle with the U.S. Surgeon General during his visit.

Advertisement

Cleveland Clinic also contributes to the consortium through its sheer size. “We are the largest and most regionally distributed medical organization in Northeast Ohio,” notes Dr. Streem. “We can often leverage technology and our system’s resources to track opiate-seeking patients and get people connected with an addiction treatment program.”

No system can go it alone

Despite its network of resources, Cleveland Clinic can’t tackle the opioid crisis alone. “Information sharing is a critical part of the solution to the opiate epidemic,” says Dr. Streem. “The more pathways and procedures that can be created to facilitate information sharing, the more those systems are able to control demand for opiates and their flow into the community.”

Member partners in the opioid consortium share best practices related to the electronic medical record (EMR). For example, MetroHealth’s EMR system includes an alert so that when a patient receives a prescription for an opiate, physicians are queried if they want to also prescribe naloxone. Cleveland Clinic plans to adopt a similar alert. In addition, the consortium rolled out an addiction awareness program to educate nurses throughout Northeast Ohio and offers training on buprenorphine medication-assisted treatment.

Advice for other providers

Dr. Streem offers the following advice to healthcare providers trying to curb the opioid crisis:

  • Educate patients about pain relief medication. “The anesthesiology and perioperative groups at Cleveland Clinic have done a great job educating patients who are going to have a surgical procedure on what we are doing to reduce their exposure to very potent opiates while still managing their pain,” he says.
  • Minimize needless variations in prescribing practices. “One of the big problems in healthcare is that you have multiple surgeons doing the same surgery within a hospital system, yet their prescribing habits for opiates following discharge can be wildly different,” he observes. “A lot of surgical services at Cleveland Clinic have done a much better job reducing not only the total amount of opiates prescribed but also the variation among providers.”
  • Make naloxone easily accessible and affordable. In April, the FDA approved the first generic naloxone hydrochloride nasal spray to help make the overdose reversal treatment more readily available. Anyone can obtain naloxone from any Cleveland Clinic pharmacy in Ohio without a prescription.
  • Encourage proper disposal of unused opiates. Cleveland Clinic has increased the number of secure drug drop-off boxes throughout Northeast Ohio.
  • Screen the addiction population for co-occurring psychiatric disorders. In particular, Cleveland Clinic screens for depression, anxiety disorders, trauma and PTSD. “We track severity levels of those conditions and try to measure improvements in scores over the course of a multilevel continuum of care,” Dr. Streem notes.

Advertisement

“Whether we admit it to ourselves or not, much of the healthcare system played some role in the development of this crisis,” he concludes. “Now we need to be part of the solution.”

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad